139 related articles for article (PubMed ID: 2141075)
1. Pharmacokinetic profile of two aromatic retinoids (etretinate and acitretin) in the obese Zucker rat.
McNamara PJ; Blouin RA
J Pharm Sci; 1990 Apr; 79(4):301-4. PubMed ID: 2141075
[TBL] [Abstract][Full Text] [Related]
2. Influence of pregnancy on the pharmacokinetic disposition of two aromatic retinoids (etretinate and acitretin) in the rat. I. Intravenous studies.
Brouwer KR; McNamara PJ
Drug Metab Dispos; 1989; 17(6):646-51. PubMed ID: 2575501
[TBL] [Abstract][Full Text] [Related]
3. Systemic pharmacokinetics of acitretin, etretinate, isotretinoin, and acetylenic retinoids in guinea pigs and obese rats.
Chien DS; Sandri RB; Tang-Liu DS
Drug Metab Dispos; 1992; 20(2):211-7. PubMed ID: 1352212
[TBL] [Abstract][Full Text] [Related]
4. Influence of pregnancy on the pharmacokinetic disposition of two aromatic retinoids (etretinate and acitretin) in the rat. II. Single and multiple oral dosing studies.
Brouwer KR; McNamara PJ
Drug Metab Dispos; 1989; 17(6):652-5. PubMed ID: 2575502
[TBL] [Abstract][Full Text] [Related]
5. Kinetics of tissue distribution and elimination of retinoid drugs in the rat. II. Etretinate.
Eisenhardt EU; Bickel MH
Drug Metab Dispos; 1994; 22(1):31-5. PubMed ID: 8149886
[TBL] [Abstract][Full Text] [Related]
6. UV-induced isomerization of oral retinoids in vitro and in vivo in hairless mice.
Berne B; Rollman O; Vahlquist A
Photodermatol Photoimmunol Photomed; 1990 Aug; 7(4):146-52. PubMed ID: 2150173
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacokinetics of etretinate, acitretin and 13-cis-acitretin: new results and advantages of blood level oriented clinical use].
Gollnick H; Rinck G; Bitterling T; Orfanos CE
Z Hautkr; 1990 Jan; 65(1):40-50. PubMed ID: 2139274
[TBL] [Abstract][Full Text] [Related]
8. Acitretin : A Review of its Pharmacology and Therapeutic Use.
Pilkington T; Brogden RN
Drugs; 1992 Apr; 43(4):597-627. PubMed ID: 28421560
[TBL] [Abstract][Full Text] [Related]
9. Acitretin versus etretinate in psoriasis. Clinical and pharmacokinetic results of a German multicenter study.
Gollnick H; Bauer R; Brindley C; Orfanos CE; Plewig G; Wokalek H; Hoting E
J Am Acad Dermatol; 1988 Sep; 19(3):458-68. PubMed ID: 2971692
[TBL] [Abstract][Full Text] [Related]
10. Transplacental pharmacokinetics of teratogenic doses of etretinate and other aromatic retinoids in mice.
Reiners J; Löfberg B; Kraft JC; Kochhar DM; Nau H
Reprod Toxicol; 1988; 2(1):19-29. PubMed ID: 2980988
[TBL] [Abstract][Full Text] [Related]
11. High-performance liquid chromatographic determination of etretinate and all-trans- and 13-cis-acitretin in human plasma.
De Leenheer AP; Lambert WE; De Bersaques JP; Kint AH
J Chromatogr; 1990 Feb; 500():637-42. PubMed ID: 2139439
[TBL] [Abstract][Full Text] [Related]
12. Teratogenicity of steady-state concentrations of etretinate and metabolite acitretin maintained in maternal plasma and embryo by intragastric infusion during organogenesis in the mouse: a possible model for the extended elimination phase in human therapy.
Löfberg B; Reiners J; Spielmann H; Nau H
Dev Pharmacol Ther; 1990; 15(1):45-51. PubMed ID: 2147001
[TBL] [Abstract][Full Text] [Related]
13. Acitretin versus etretinate in severe psoriasis. A double-blind randomized Nordic multicenter study in 168 patients.
Bjerke JR; Geiger JM
Acta Derm Venereol Suppl (Stockh); 1989; 146():206-7. PubMed ID: 2532847
[TBL] [Abstract][Full Text] [Related]
14. Quantitative analysis of retinoids in biological fluids by high-performance liquid chromatography using column switching. II. Simultaneous determination of etretinate, acitretin and 13-cis-acitretin in plasma.
Wyss R; Bucheli F
J Chromatogr; 1988 Oct; 431(2):297-307. PubMed ID: 2977389
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of etretin and etretinate during long-term treatment of psoriasis patients.
Larsen FG; Jakobsen P; Larsen CG; Kragballe K; Nielsen-Kudsk F
Pharmacol Toxicol; 1988 Mar; 62(3):159-65. PubMed ID: 2967472
[TBL] [Abstract][Full Text] [Related]
16. Teratogenicity of etretinate during early pregnancy in the rat and its correlation with maternal plasma concentrations of the drug.
Agnish ND; Vane FM; Rusin G; DiNardo B; Dashman T
Teratology; 1990 Jul; 42(1):25-33. PubMed ID: 2144063
[TBL] [Abstract][Full Text] [Related]
17. In vitro interactions of the aromatic retinoids Ro 10-9359 (etretinate) and Ro 10-1670 (acitretin), its main metabolite, with human serum lipoproteins and albumin.
Carillet V; Morlière P; Mazière JC; Hüppe G; Santus R; Dubertret L
Biochim Biophys Acta; 1990 Nov; 1055(2):98-101. PubMed ID: 2146977
[TBL] [Abstract][Full Text] [Related]
18. The pharmacokinetics of etretinate and its metabolites in the dog.
Thongnopnua P; Massarella JW; Zimmerman CL
Drug Metab Dispos; 1989; 17(5):473-80. PubMed ID: 2573489
[TBL] [Abstract][Full Text] [Related]
19. The pharmacokinetics of acitretin and its 13-cis-metabolite in psoriatic patients.
Larsen FG; Jakobsen P; Eriksen H; Grønhøj J; Kragballe K; Nielsen-Kudsk F
J Clin Pharmacol; 1991 May; 31(5):477-83. PubMed ID: 1828811
[TBL] [Abstract][Full Text] [Related]
20. Single dose pharmacokinetics of etretin and etretinate in psoriatic patients.
Larsen FG; Jakobsen P; Larsen CG; Nørgaard A; Kragballe K; Nielsen-Kudsk F
Pharmacol Toxicol; 1987 Aug; 61(2):85-8. PubMed ID: 2959917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
